Markets.com Logo

SRPT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    19.3955$
  • Previous Close
    20.254$
  • 52 Week Change
    131.31$
  • Day Range
    -0.86$
  • 52 Week High/Low
    10.415$ - 141.72$
  • Dividend Per Share
    --
  • Market cap
    2 011 M$
  • EPS
    2.02
  • Beta
    0.455
  • Volume
    --

About

SRPT.US represents Sarepta Therapeutics Inc., a commercial-stage biopharmaceutical company focused on precision genetic medicine for rare diseases. The company's primary focus is on developing and marketing therapies for Duchenne muscular dystrophy (DMD), a genetic disorder that primarily affects boys. Sarepta has multiple approved therapies for DMD and a robust pipeline of gene therapy and RNA-based programs targeting various genetic mutations and other neuromuscular diseases. The company's financial performance and stock price are influenced by clinical trial results, regulatory approvals, sales of its DMD therapies, and advancements in its research and development pipeline.
Trending tech stock analysis: Is Super Micro (SMCI) a good stock to buy?

Trending tech stock analysis: Is Super Micro (SMCI) a good stock to buy?

Ghko B|--
NIO stock price prediction 2026: NIO shares jump 1.8%, what’s next?

NIO stock price prediction 2026: NIO shares jump 1.8%, what’s next?

Ghko B|--
Forex market analysis: EUR/USD slides, GBP/USD down, USD/JPY rises

Forex market analysis: EUR/USD slides, GBP/USD down, USD/JPY rises

Frances Wang|--
Super Micro (SMCI) Stock: What is the stock price forecast for SMCI 2026?

Super Micro (SMCI) Stock: What is the stock price forecast for SMCI 2026?

Ghko B|--
Ethereum price prediction 2026: What’s driving Ethereum’s value (ETH/USD)?

Ethereum price prediction 2026: What’s driving Ethereum’s value (ETH/USD)?

Ghko B|--
Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Ghko B|--
Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Ghko B|--

Factors

Clinical Trial Results: Positive outcomes significantly increase the stock price, while negative results lead to a decrease. Regulatory Approvals: FDA approval of new therapies boosts investor confidence and the stock's value. Conversely, regulatory delays or rejections have a negative impact. Market Competition: The presence of competing drugs or therapies influences SRPT's market share and profitability, affecting its stock price. Financial Performance: Revenue growth, profitability, and cash flow impact investor sentiment and the stock's valuation. Overall Market Conditions: Broader economic trends and market sentiment can influence the trading activity and price of SRPT. Company-Specific News: Announcements regarding partnerships, acquisitions, or other strategic initiatives can move the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Beginner's guide to CFD trading: How to trade CFDs in six steps?

Beginner's guide to CFD trading: How to trade CFDs in six steps?

Ghko B|--
What is FTSE 100 Index: How to trade FTSE 100 Index CFDs with markets.com?

What is FTSE 100 Index: How to trade FTSE 100 Index CFDs with markets.com?

Ghko B|--
Moving average indicator: What is the best indicator for moving average?

Moving average indicator: What is the best indicator for moving average?

Ghko B|--